Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous temozolomide in metastatic melanoma (Phase II)
2004-002925-39Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Dec 2004
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in melanoma, sponsored by Karolinska University Hospital. Primary endpoint: Tumor response rate. Started Dec 2004; status: active.
02
Drugs
temozolomide
03
Conditions
melanoma
Beyond the preview
Go deeper on 2004-002925-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002925-39.